CATALOGO DEI PRODOTTI DELLA RICERCA

BENCIVENGA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.332
NA - Nord America 4.225
AS - Asia 3.309
SA - Sud America 514
AF - Africa 166
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.123
RU - Federazione Russa 2.066
SG - Singapore 1.331
CN - Cina 875
GB - Regno Unito 551
IT - Italia 490
BR - Brasile 411
VN - Vietnam 377
HK - Hong Kong 285
SE - Svezia 225
IE - Irlanda 223
DE - Germania 217
FR - Francia 187
KR - Corea 116
FI - Finlandia 115
JP - Giappone 63
CA - Canada 51
UA - Ucraina 50
ES - Italia 46
IN - India 39
AR - Argentina 38
NL - Olanda 36
ID - Indonesia 35
ZA - Sudafrica 33
BD - Bangladesh 32
AT - Austria 31
MX - Messico 31
TG - Togo 24
IQ - Iraq 22
NG - Nigeria 22
RW - Ruanda 22
BJ - Benin 20
IL - Israele 18
TR - Turchia 18
PL - Polonia 17
BE - Belgio 16
EC - Ecuador 14
UZ - Uzbekistan 13
AU - Australia 12
PY - Paraguay 12
LT - Lituania 11
PK - Pakistan 11
CL - Cile 10
CO - Colombia 10
DZ - Algeria 8
JO - Giordania 8
AE - Emirati Arabi Uniti 7
KG - Kirghizistan 7
PH - Filippine 7
PT - Portogallo 7
TW - Taiwan 7
VE - Venezuela 7
EG - Egitto 6
GR - Grecia 6
CR - Costa Rica 5
KE - Kenya 5
MA - Marocco 5
NO - Norvegia 5
PE - Perù 5
SA - Arabia Saudita 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
MY - Malesia 4
TN - Tunisia 4
AL - Albania 3
AO - Angola 3
CZ - Repubblica Ceca 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
XK - ???statistics.table.value.countryCode.XK??? 3
CG - Congo 2
CM - Camerun 2
DK - Danimarca 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
Totale 12.549
Salva come PNG Salva come JPEG
Città #
Singapore 706
Moscow 697
Ashburn 637
San Jose 455
Southend 413
Chandler 407
Dallas 385
Hong Kong 279
Verona 270
Dublin 219
Beijing 167
Jacksonville 157
The Dalles 153
New York 132
Ho Chi Minh City 125
Los Angeles 118
Ann Arbor 93
Redmond 78
Woodbridge 74
Hanoi 71
Munich 70
Houston 68
Lawrence 62
Princeton 62
Helsinki 61
Tokyo 57
Jinan 56
São Paulo 49
Wilmington 48
Nanjing 45
Council Bluffs 44
Shenyang 38
London 36
Buffalo 35
Redondo Beach 33
Columbus 32
Santa Clara 32
Seoul 30
Milan 29
Hebei 27
Sindelfingen 27
Tianjin 26
Amsterdam 24
Dong Ket 24
Lomé 24
Atlanta 23
Orem 23
Frankfurt am Main 22
Jakarta 22
Kigali 22
Abuja 21
Brooklyn 20
Changsha 20
Cotonou 20
Guangzhou 20
Johannesburg 18
San Francisco 18
Seattle 18
Vienna 18
Denver 17
Haikou 17
Brussels 16
Falls Church 16
Madrid 16
Stockholm 16
Lappeenranta 15
Nanchang 15
Nuremberg 15
Turku 15
Chennai 14
Chicago 14
Haiphong 14
Montreal 14
Ningbo 14
Taizhou 14
Zhengzhou 14
Mexico City 13
Washington 13
Belo Horizonte 12
Hangzhou 12
Manchester 12
Paris 12
Toronto 12
Warsaw 12
Jiaxing 11
Shanghai 11
Tashkent 11
Boston 10
Da Nang 10
Phoenix 10
Rio de Janeiro 10
Baghdad 9
Falkenstein 9
Fuzhou 9
Poplar 9
Rome 9
Ankara 8
Biên Hòa 8
Boardman 8
Brasília 8
Totale 7.464
Salva come PNG Salva come JPEG
Nome #
Genomic characterization of hepatoid tumors: context matters 260
Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer. 227
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 225
Shape and volume of internal anal sphincter showed by three-dimensional anorectal ultrasonography 209
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 205
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 200
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 198
Methylation Dynamics of RASSF1A and Its Impact on Cancer 194
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 193
Clinical pathways in gastric cancer care 191
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 191
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 187
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 187
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 185
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 182
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 178
One stage or two stage treatment of colorectal cancer associated to abdominal aortic aneurysm: morbidity and mortality. 175
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 173
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 172
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 170
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 168
Short-term and long-term risk factors in gastric cancer 167
Lymphadenectomy for gastric cancer at European specialist centres 162
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 159
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 158
Do all the European surgeons perform the same D2? The need of D2 audit in Europe 154
Complications after gastrectomy for cancer: Italian perspective 153
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 153
Western strategy for EGJ carcinoma 152
Management of critically ill surgical patients Case reports 150
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 150
Tailored treatment for signet ring cell gastric cancer 150
Lymphadenectomy: how to do it? 146
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 144
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 144
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 143
A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194 143
Personalized therapeutic strategies in HER2-driven gastric cancer 143
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 142
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 142
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 139
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 138
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 135
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 135
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 135
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 134
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits 133
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 133
An aggressive early gastric cancer: Kodama's PenA type 132
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 129
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 127
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 126
Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer 126
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 122
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment 122
Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy 120
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition 119
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 117
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 116
Surgical treatment of hepatic metastases from gastric cancer 116
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer 110
Beyond years: evaluating the impact of surgeon age on outcomes after gastric cancer surgery 109
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 109
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 108
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 107
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape 107
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study 107
Genomic events stratifying prognosis of early gastric cancer 104
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial 104
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 103
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 103
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series 100
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases 99
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 96
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis 92
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study 91
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer 81
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe 80
Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA Registry 78
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022 78
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden 77
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples 77
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 76
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 76
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 76
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis 76
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial 76
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 72
Association between ERAS protocol and major postoperative complications and reasons for non-compliance in patients with esophageal cancer 71
Prophylactic Total Gastrectomy: Techniques 68
On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer 67
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas 65
International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning 62
Defining benchmarks for total and distal gastrectomy: global multicentre analysis 59
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer 55
Upper Gastrointestinal Bleeding 52
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment 43
Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study 29
Incidence of non-colorectal/endometrial malignancies in individuals with Lynch syndrome: a retrospective cohort study 26
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO 25
Totale 12.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.394
article - articoli 41.934
book - libri 0
conference - conferenze 462
curatela - curatele 0
other - altro 632
patent - brevetti 0
selected - selezionate 0
volume - volumi 366
Totale 86.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 10 66 53
2021/2022534 25 120 26 42 33 23 8 41 18 30 30 138
2022/20231.276 73 140 102 217 105 319 7 104 129 11 32 37
2023/2024848 17 58 57 97 65 168 40 47 16 75 151 57
2024/20252.055 94 97 93 343 103 69 163 123 279 172 164 355
2025/20266.497 414 326 428 1.200 1.736 421 635 394 548 395 0 0
Totale 12.753